Demuys JM[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
1988	1
1989	1
1997	1
2002	1
2022	0

Page 1

Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.

Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G. Gourdeau H, et al. Among authors: demuys jm. Cancer Chemother Pharmacol. 2002 Dec;50(6):490-6. doi: 10.1007/s00280-002-0530-7. Epub 2002 Oct 16. Cancer Chemother Pharmacol. 2002. PMID: 12451476

Interindividual variation in phase II detoxification enzymes in normal human colon mucosa.

Batist G, Mekhail-Ishak K, Hudson N, DeMuys JM. Batist G, et al. Among authors: demuys jm. Biochem Pharmacol. 1988 Nov 1;37(21):4241-3. doi: 10.1016/0006-2952(88)90123-2. Biochem Pharmacol. 1988. PMID: 2903744 No abstract available.

Enhanced DNA cross-link removal: the apparent mechanism of resistance in a clinically relevant melphalan-resistant human breast cancer cell line.

Batist G, Torres-Garcia S, Demuys JM, Greene D, Lehnert S, Rochon M, Panasci L. Batist G, et al. Among authors: demuys jm. Mol Pharmacol. 1989 Aug;36(2):224-30. Mol Pharmacol. 1989. PMID: 2770701

Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.

Kadhim SA, Bowlin TL, Waud WR, Angers EG, Bibeau L, DeMuys JM, Bednarski K, Cimpoia A, Attardo G. Kadhim SA, et al. Among authors: demuys jm. Cancer Res. 1997 Nov 1;57(21):4803-10. Cancer Res. 1997. PMID: 9354442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results